Singulair is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short-acting ß-agonists provide inadequate clinical control of asthma. (Please consult your physician before taking any medication).
Singulair 4mg
- Scientific Name: Montelukast sodium 4mg.
- Drag Period: twice daily (every 12 hours)
- Type: Tablets
- Producing Company: MSD ( Merck sharpe - Dohme )
- About Montelukast Leukotriene(CysLT1) Receptor Antagonist, Antiinflammatory,antiasthma. Mechanism of Action of Montelukast Montelukast is competitively and selectively antagonizes CysLT1 receptor (leukotrienes receptor) mediated Bronchoconstriction.Montelukast inhibits physiologic actions of LTD 4 at the CysLT1 receptor without any agonist activity. Indications for Montelukast Asthma. Interactions for Montelukast Barbiturates & Primidone: Plasma concentration of montelukast is reduced by phenobarbital.
